We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

172 hedge funds and large institutions have $542M invested in Meridian Bioscience Inc in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 51 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $262K | Put options by funds: $153K

16% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 51

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

1% more funds holding

Funds holding: 170 → 172 (+2)

8% less capital invested

Capital invested by funds: $592M → $542M (-$50M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
172
Holders Change
+2
Holders Change %
+1.18%
% of All Funds
4.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
59
Reduced
51
Closed
18
Calls
$262K
Puts
$153K
Net Calls
+$109K
Net Calls Change
-$144K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$5.65M
2
SCM
SG Capital Management
Illinois
+$5.23M
3
Morgan Stanley
Morgan Stanley
New York
+$4.12M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.21M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6.82M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$5.79M
3
IECM
Intrinsic Edge Capital Management
Illinois
-$3.9M
4
BCM
Brown Capital Management
Maryland
-$2.24M
5
HEC
Hudson Executive Capital
New York
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
BLA
176
Balter Liquid Alternatives
Massachusetts
– -$590K -37,485 Closed
HHC
177
Hutchin Hill Capital
New York
– -$578K -36,700 Closed
3C
178
361 Capital
Colorado
– -$378K -23,988 Closed
Squarepoint
179
Squarepoint
New York
– -$293K -18,574 Closed
JFG
180
Jefferies Financial Group
New York
– -$197K -12,513 Closed
PTC
181
Petrus Trust Company
Texas
– -$178K -11,302 Closed
VIA
182
Vident Investment Advisory
Georgia
– -$170K -10,771 Closed
AIM
183
Acrospire Investment Management
Illinois
– -$93K -5,880 Closed
Walleye Trading
184
Walleye Trading
New York
– -$54 -3,400 Closed
SWA
185
Sutton Wealth Advisors
Florida
– -$16.6K -1,051 Closed
FMA
186
FNY Managed Accounts
New York
– -$14K -951 Closed
OIA
187
OneDigital Investment Advisors
Kansas
– -$9K -600 Closed
WA
188
Winfield Associates
Ohio
– -$4K -232 Closed
BAM
189
Bruderman Asset Management
New York
– -$3K -163 Closed
Group One Trading
190
Group One Trading
Illinois
– -$1.39K -97 Closed
4 5 6 7
8

VIVO Hedge Fund Activity: Q3 2017 in Review

172 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2017, worth a combined $542M — down 8.5% from $592M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VIVO positions and 18 closed out — a net gain of 2 holders — while 59 added to existing stakes and 51 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.65M. The largest seller was UBS Group, cutting an estimated $6.82M.

  • 172 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2017, up from 170 in Q2 2017.
  • Funds reported $542M of Meridian Bioscience Inc stock for Q3 2017, down 8.5% quarter-over-quarter.
  • 20 funds opened new Meridian Bioscience Inc positions in Q3 2017 and 18 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2017 was Millennium Management, an estimated $5.65M added.
  • The largest Meridian Bioscience Inc seller in Q3 2017 was UBS Group, an estimated $6.82M sold.

Based on aggregated 13F filings for Q3 2017.